immune system
• reduction in the serum level of IFNG is seen compared to diabetic and non-diabetic NOD mice
|
• a reduction in the serum level of IL-2 is observed compared to diabetic and non-diabetic NOD mice
|
• no female mutants develop diabetes (blood glucose levels above 13.9 mmol/l for 3 readings) over a 10-month period compared with 74% of female wild-type Stat4 NOD mice, which is similar to female NOD mice (80%)
|
• noc cellular infiltration is observed at 40 weeks of age compared to massive and invasive cellular infiltration seen in diabetic NOD controls and heterozygous Stat4 NOD or wild-type Stat4 mice
• a significant reduction in the numbers of CD4+ and CD8+ cells in islets is observed compared to diabetic NOD mice
|
endocrine/exocrine glands
• well-preserved insulin-positive cells are seen in the islets of mutants whereas such cells are rare in Stat4 heterozygous and wild-type Stat4 NOD mice
|
• compared to NOD controls, islets in Stat4 null NOD mice show well preserved insulin secretion at basal glucose levels and in response to high glucose
|
homeostasis/metabolism
• compared to NOD controls, islets in Stat4 null NOD mice show well preserved insulin secretion at basal glucose levels and in response to high glucose
|
• reduction in the serum level of IFNG is seen compared to diabetic and non-diabetic NOD mice
|
• a reduction in the serum level of IL-2 is observed compared to diabetic and non-diabetic NOD mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
NOT | type 1 diabetes mellitus | DOID:9744 |
OMIM:222100 |
J:90600 |